The largest database of trusted experimental protocols

33 protocols using anti cd28 clone 37

1

Expansion of CD8+ T Cells In Vitro

Check if the same lab product or an alternative is used in the 5 most similar protocols
An untreated, flat-bottom, 96-well plate was coated overnight at 4°C with 0.2 μg/mL anti-CD3 (clone 145-2C11, BD Biosciences) and 0.5 μg/mL anti-CD28 (clone 37.51, BD Biosciences) in PBS, washed with PBS, and blocked with coculture media (RPMI from Gibco containing 10% FBS from Atlanta Biologicals, 1% penicillin/streptomycin from Gibco, and 1× β-mercaptoethanol from Gibco) for at least 30 minutes at room temperature (RT). CD8+ T cells were isolated from the spleens of naive C57BL/6 mice using the untouched CD8+ T cell isolation kit (Miltenyi Biotec), following manufacturer’s instructions. Isolated CD8+ T cells were washed twice with PBS and stained with CTV dye (Life Technologies) following manufacturer’s instructions. Dye-labeled CD8+ T cells were then cultured on the anti-CD3/anti-CD28–coated plate at a density of 105 cells per well in coculture media, and 2 μg/mL anti–IL-2 (using a mixture of both S4B6-1 and JES6-1A12 clones, Bio X Cell) was added at the beginning of coculture where indicated. The cells were cultured at 37°C and 5% CO2 for 3 days. Following coculture, cells were stained and analyzed by flow cytometry.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescein isothiocyanate (FITC), Allophycocyanin cyanine tandem (APC-H7), R-phycoerythrin (PE) or Allophycocyanin (APC)-conjugated monoclonal antibodies (mAbs) were used for cytofluorometric analysis of anti-mouse Ki67 (BD PharMingen, San Diego, CA, USA), anti-mouse CD4, anti-mouse CD25 and anti-mouse FoxP3 (eBioscience, San Diego, CA). Purified hamster anti-mouse mAbs, anti-CD3 (clone 145-2C11) and anti-CD28 (clone 37.51) were also purchased from BD Pharmingen. Recombinant TGF-β was purchased from Peprotech (NJ, USA). TGF-β neutralizing mAb (1D11) was a gift from Dr. Hong-Ming Hu (Earle A. Chiles Research Institute, Portland, OR). Cell enrichment kits for CD4+ and Antigen Presenting Cells (APC, CD90.1) were purchased from MACS Miltenyi Biotec Inc., (Auburn, CA, USA). Dead Fixable Violet Dead Cell Stain Kit was purchased from Invitrogen (L34955, Carlsbad, CA).
+ Open protocol
+ Expand
3

MDSC-Mediated T Cell Suppression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine T cells were enriched from wild-type mouse splenocytes by negative selection using a murine pan-T-cell isolation kit (EasySep, StemCell). To monitor T-cell proliferation, isolated T cells were stained with 2.5 µM CellTrace Violet (Invitrogen) according to the manufacturer’s instructions.
Murine MDSCs were isolated from the splenocytes of tumor-bearing mice by negative selection using a murine MDSC isolation kit (EasySep, StemCell). As indicated, the obtained MDSCs were used immediately or pretreated with sialidase as described below.
Isolated MDSCs and T cells were plated at a ratio of 1:1 in a 96-well flat bottom plate and cocultured for 48 h in complete RPMI in the presence of 50 IU of IL-2 (proleukin). For T-cell stimulation, the plate was coated with anti-CD3 (clone 17A2; BioLegend) and anti-CD28 (clone 37.51; BD Biosciences) antibodies. The supernatants were frozen at −80 °C, and the cells were stained for flow cytometry.
For Siglec-E blocking, purified anti-mouse Siglec-E antibody (M1305A02; BioLegend) or rat IgG2a or κ isotype control (BioLegend) was added at a final concentration of 10 µg/mL. CCL2 blocking was performed by the addition of 50 µg/mL CCL2 (Clone 2H5, BD).
+ Open protocol
+ Expand
4

Proliferation Assay for Splenocyte Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation assays were performed as previously described
[15 (link)]. In brief, splenocytes were isolated from C57BL/6 adult mice or fetal sheep and seeded in 96-well, flat-bottom microtiter plates (Nunc, Thermo Fisher Scientific, Australia). Assays were performed in triplicate at a concentration of 2.5 × 105 cells per well in complete RPMI medium alone or in the presence of 5 μl/ml concanavalin A (ConA; Sigma-Aldrich), or into wells precoated with 10 μg/ml anti-CD3 (clone 145-2C11) and 10 μg/ml anti-CD28 (clone 37.51) antibodies (both from BD Biosciences) to a final volume of 200 μl per well. For wells that required addition of hAECs, 50 μl of hAECs that had been exposed to surfactant or PBS, at hAEC-to-splenocyte ratios ranging from 1:5 to 1:40, were added to each well before the addition of splenocytes. Cells were incubated at 37°C for 48 hours and then 1 μCi/well [3H]-thymidine (Perkin Elmer, Waltham, MA, USA) was added for an additional 18 hours of culture. Cells were harvested onto filter mats (Perkin Elmer), and incorporated radioactive nucleic acids were counted by using a Top Count Harvester (Packard Biosciences, Meriden, CT, USA).
+ Open protocol
+ Expand
5

Splenocyte Activation and Expansion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untreated, flat-bottom, 24-well plates were coated overnight at 4°C with 0.2 μg/mL anti-CD3 (clone 145-2C11, BD Biosciences) and 0.5 μg/mL anti-CD28 (clone 37.51, BD Biosciences) in PBS, washed with PBS, and blocked with coculture media for at least 30 minutes at RT. Erythrocytes were removed with ACK lysing buffer (Gibco), and splenocytes were plated at 1.2 × 106 per well. Splenocytes were activated for 96 hours before being moved to 6-well plates, and fresh medium was added at a 1:1 ratio. Splenocytes were allowed to expand further 72 hours.
+ Open protocol
+ Expand
6

Profiling Tregs and Tconv by Proteomics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tregs and Tconv were profiled by proteome and quantitative phosphopeptide sequencing (van Ham et al., under preparation). In brief, CD4+CD25+ Tregs and CD4+CD25 Tconv were ex vivo isolated from single cell suspensions of pooled spleen and lymph node (LN) cells from BALB/c mice by MACS-based enrichment of CD4+ T cells using direct beads (L3T4, Miltenyi Biotec) followed by flow cytometry-based sorting to high purity. For proteome analysis, sorted T cell subsets were left unstimulated. For quantitative phosphopeptide sequencing, cells were either left unstimulated or stimulated by decoration with biotinylated anti-CD3 (clone145-2C11, BD Biosciences) and anti-CD28 (clone 37.51, BD Biosciences) and subsequent antibody crosslinking using streptavidin. Stimulation was stopped after 5 min with an excess of ice cold PBS and cells were further processed for liquid chromatography – tandem mass spectrometry (LC–MS/MS) (further experimental details available on request).
+ Open protocol
+ Expand
7

Isolation and Activation of CD4+ T and B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4+ T and B cells were purified by negative selection using MACS systems (Miltenyi Biotec). CD4+PD1+CXCR5+ cells were sorted by FACS after staining with FITC-conjugated PD1, phycoerythrin-conjugated CD4, and PerCP-conjugated CXCR5 antibodies. Purified CD4+ T cells were stimulated with plate-bound anti-CD3 (clone 145-2C11, BD Biosciences) at 5 μg/ml or at the indicated concentrations and anti-CD28 (clone 37.51, BD Bioscience) (2 μg/ml) antibodies for the indicated times. B cells were activated with soluble anti-F(ab′)2 fragments of goat anti-mouse IgM (anti-IgM F(ab′)2, Jackson ImmunoResearch Laboratories, Inc.) at 5 μg/ml for the indicated times.
+ Open protocol
+ Expand
8

Cultivation and Differentiation of Melanoma Cell Lines and CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B16-F1 and B16-F10 melanoma cell lines were purchased from the American Type Culture Collection (ATCC). A highly aggressive subclone of B16-F10 (B16-M1) was generated by isolating and expanding a metastatic clone that arose in a C57BL/6 mouse 6 weeks after surgical removal of an established primary tumor. The B16-OVA melanoma cell line was kindly provided by E.M. Lord (University of Rochester Medical Center, Rochester, NY). The expression of OVA by B16-OVA cells was confirmed by real time PCR. All melanoma cells were cultured in DMEM (Thermo Scientific) supplemented with 10% heat inactivated FBS, 2mM L-Glutamine and 250 IU of penicillin/streptomycin.
CD4+ T cells were isolated using anti-CD4 conjugated magnetic Dynabeads (Life Technologies) according to the manufacturer’s protocol. Where indicated, CD4+ T cells were differentiated into TH1 helper cells by activation with plate-bound anti-CD3ε (clone 2C11; 0.25 μg/mL) and anti-CD28 (clone 37.51; 0.25 μg/mL) antibodies (BD Biosciences) and cultured for six days in DMEM supplemented with 10% heat inactivated FBS, 2 mM L-glutamine, 50 μM 2-mercaptoethanol, nonessential amino acids and essential vitamins (Cambrex), in the presence of murine IL-12 (10 ng/mL) (eBioscience), anti-mouse IL-4 antibody (clone 11C.11; 10 μg/ml) and 10 U/mL recombinant human IL-2 (Biological Resources Branch of the National Cancer Institute).
+ Open protocol
+ Expand
9

Analyzing T-cell Cytokine Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung cells were incubated for 1 h in the presence of 1 μg/ml anti-CD28 (clone 37.51; BD Pharmingen) and anti-CD49d (clone 9C10 (MFR4.B); BD Pharmingen) followed by 5 h with 10 μg/ml brefeldin A (Sigma-Aldrich) and 1:1500 BD GolgiStop (BD Biosciences) at 37°C in an automated heater that cooled the cells to 4°C after incubation. The next day, cells were washed in FACS buffer (PBS containing 0.1% sodium azide and 1% FCS) and stained at 4°C for surface markers using anti-CD4-APC-eF780 (clone RM4-5; 1/600 dilution; eBioscience) and anti-CD44-FITC (clone IM7; 1/200 dilution; BD Bioscience). After 15–30 min of surface staining, cells were washed in FACS buffer, permeabilized using the Cytofix/Cytoperm kit (BD Pharmingen) according to the manufacturer’s instructions, and stained intracellularly with anti-IL-17-PerCP-Cy5.5 (clone eBio17B7; 1/200 dilution; eBioscience) and anti-IFNγ-PE-Cy7 (clone XMG1.2; 1/200, eBioscience) mAbs. Cells were subsequently washed, resuspended in FACS buffer and analyzed on a BD FACSCanto flow cytometer (BD Biosciences). In vivo staining with anti-CD45.2: Anti-CD45.2-FITC (clone 104; BD Pharmingen) was diluted to 10μg/ml in sterile Phosphate-buffered saline (PBS). 250μl of the aCD45.2 solution was injected i.v. into each mouse via the tail vein, three minutes before euthanization of the mice. Data was analyzed using FlowJo v10.0.7 for Windows.
+ Open protocol
+ Expand
10

IFN-γ ELISpot Assays for Influenza A

Check if the same lab product or an alternative is used in the 5 most similar protocols
IFN-γ ELISpot assays were performed using a commercial kit from Abcam (ab64029) following the manufacturer’s recommendations. Cells were stimulated with 1.25 μg/ml anti-CD28 (Clone 37.51, BD) and premade 15-mer sequences with 11 amino acids overlap peptides from influenza A (H1N1) HA (Peptivator, Miltenyi Biotech) or NA (PepMixTM, JPT). Spots were counted using the AID iSpot reader and ELISpot Reader software V 7.0.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!